Literature DB >> 31131596

Renal Infarction in a Young Man

Zehra Eren1, Hakan Koyuncu2.   

Abstract

Entities:  

Year:  2019        PMID: 31131596      PMCID: PMC6711250          DOI: 10.4274/balkanmedj.galenos.2019.2019.1.73

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


× No keyword cloud information.
A 43-year-old man presented to the emergency department with a 1-h history of severe abdominal pain, particularly localized in the umbilical area and accompanied by cold sweating. His medical history was unremarkable. Abdominal examination revealed no defense or rebound tenderness (1). Vital signs as well as systemic and laboratory findings were normal, except for the elevated levels of aspartate aminotransferase (120 U/L; reference range, <46 U/L) and lactate dehydrogenase (977 U/L; reference range, 135-225 U/L), indicating signs of damage in the body tissues. Abdominal ultrasonography revealed normal findings, and doppler ultrasonography revealed no flow in the left inferior segmental renal artery. Furthermore, abdominal computed tomography with contrast revealed a hypodense area in the left kidney involving the anterolateral component of the upper and middle zones in addition to the entire lower pole (Figure 1). Selective renal angiography performed to rule out pathologies that require interventions (stenosis of a large artery, dissection) demonstrated 80% stenosis in the middle inferior segmental renal artery (Figure 2). A diagnosis of renal infarction was made, and treatment with enoxaparin (2×0.6 mL/day) was initiated (2). The patient’s pain resolved within the next 24 h; however, the levels of aspartate aminotransferase and lactate dehydrogenase continued to increase. Clopidogrel (75 mg/day) and aspirin (100 mg/day) were added to the treatment. The elevated enzyme levels began to decrease after 48 h of presentation, and the renal functions remained normal. Further investigation to determine the etiology of the infarction (presence of malignancy and hematological problems) revealed normal results; therefore, we determined this case as idiopathic. Although the patient’s renal function remained normal, 99mTc-dimercaptosuccinic acid renal scintigraphy performed 1 month later revealed cortical defects in the upper and lower lateral poles of the left kidney (Figure 3). Written informed consent was obtained from the patient.
Figure 1

Abdominal computed tomography with contrast showing a hypodense area in the left kidney involving the anterolateral component of the upper and middle zones and the entire lower pole.

Figure 2

Selective renal angiography showing 80% stenosis in the middle inferior segmental renal artery.

Figure 3

99mTc-dimercaptosuccinic acid renal scintigraphy showing cortical defects in the upper and lower lateral poles of the left kidney (anterior position).

  2 in total

Review 1.  Renal infarction in the ED: 10-year experience and review of the literature.

Authors:  Meir Antopolsky; Natalia Simanovsky; Ruth Stalnikowicz; Shaden Salameh; Nurith Hiller
Journal:  Am J Emerg Med       Date:  2011-08-25       Impact factor: 2.469

2.  Clinical Characteristics and Outcomes of Renal Infarction.

Authors:  Yun Kuy Oh; Chul Woo Yang; Yong-Lim Kim; Shin-Wook Kang; Cheol Whee Park; Yon Su Kim; Eun Young Lee; Byoung Geun Han; Sang Ho Lee; Su-Hyun Kim; Hajeong Lee; Chun Soo Lim
Journal:  Am J Kidney Dis       Date:  2015-11-04       Impact factor: 8.860

  2 in total
  2 in total

1.  Renal infaction in a patient with COVID-19.

Authors:  Guillermo Cuevas Tascón; Danilo E Salazar Chiriboga; Rosa Lorente Ramos; Domingo Díaz Díaz; Covadonga Rodríguez Ruiz; Fabio L Procaccini; Esther Torres Aguilera; Juan A Martín Navarro; Beatriz Mestre Gómez; Nuria Muñoz Rivas; Roberto Alcázar Arroyo
Journal:  Nefrologia (Engl Ed)       Date:  2021-02-22

2.  [Renal infaction in a patient with COVID-19].

Authors:  Guillermo Cuevas Tascón; Danilo E Salazar Chiriboga; Rosa Lorente Ramos; Domingo Díaz Díaz; Covadonga Rodríguez Ruiz; Fabio L Procaccini; Esther Torres Aguilera; Juan A Martín Navarro; Beatriz Mestre Gómez; Nuria Muñoz Rivas; Roberto Alcázar Arroyo
Journal:  Nefrologia       Date:  2020-05-14       Impact factor: 2.033

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.